Overview
Doris Chen is a primary care provider, practicing in Internal Medicine in Stanford, California. Dr. Chen is rated as an Experienced provider by MediFind in the treatment of Parinaud Oculoglandular Syndrome. Her top areas of expertise are COVID-19, Multisystem Inflammatory Syndrome in Children (MIS-C), Paris-Trousseau Thrombocytopenia, and RUNX1 Familial Platelet Disorder.
Her clinical research consists of co-authoring 1 peer reviewed article. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
Accepted plan types not found. Please verify directly with the provider.
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- HMO
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- HMO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
300 Pasteur Dr, Stanford, CA 94305
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Ki Cho is a primary care provider, practicing in Internal Medicine in Santa Clara, California. Dr. Cho is rated as an Advanced provider by MediFind in the treatment of Parinaud Oculoglandular Syndrome. His top areas of expertise are Juvenile Primary Osteoporosis, High Cholesterol, Parinaud Oculoglandular Syndrome, and Contact Dermatitis.
Stanford Health Care
Lucy Kalanithi is a primary care provider, practicing in Internal Medicine in Stanford, California. Dr. Kalanithi is rated as an Advanced provider by MediFind in the treatment of Parinaud Oculoglandular Syndrome. Her top areas of expertise are COVID-19, Multisystem Inflammatory Syndrome in Children (MIS-C), Cellulitis, and Lymphangitis.
San Joaquin Faculty Medical Group
Kanwardeep Grewal is a primary care provider, practicing in Family Medicine and Internal Medicine in French Camp, California. Dr. Grewal is rated as an Experienced provider by MediFind in the treatment of Parinaud Oculoglandular Syndrome. His top areas of expertise are Tracheitis, Parinaud Oculoglandular Syndrome, Hypertension, and Glucocorticoid-Remediable Aldosteronism.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- AcneDr. Chen isExperienced. Learn about Acne.
- Alopecia AreataDr. Chen isExperienced. Learn about Alopecia Areata.
- AnemiaDr. Chen isExperienced. Learn about Anemia.
- Autosomal Recessive HypotrichosisDr. Chen isExperienced. Learn about Autosomal Recessive Hypotrichosis.
- Chronic CoughDr. Chen isExperienced. Learn about Chronic Cough.
- COVID-19Dr. Chen isExperienced. Learn about COVID-19.